KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.02 $13.63 Friday, 26th Apr 2024 VERV stock ended at $6.16. This is 0.96% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.47% from a day low at $6.02 to a day high of $6.41.
90 days $6.02 $19.34
52 weeks $6.02 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Aug 19, 2021 $61.73 $66.88 $60.68 $64.01 196 045
Aug 18, 2021 $59.63 $63.32 $58.30 $61.99 252 670
Aug 17, 2021 $59.57 $60.47 $56.25 $59.18 233 865
Aug 16, 2021 $59.31 $60.70 $55.82 $60.00 204 337
Aug 13, 2021 $60.17 $62.46 $56.53 $60.00 237 287
Aug 12, 2021 $67.50 $67.50 $59.20 $60.09 341 592
Aug 11, 2021 $69.05 $70.00 $65.53 $67.18 133 290
Aug 10, 2021 $69.77 $69.77 $66.64 $68.99 226 259
Aug 09, 2021 $68.03 $69.99 $66.35 $69.25 272 695
Aug 06, 2021 $69.92 $70.20 $63.79 $68.08 292 452
Aug 05, 2021 $63.85 $71.34 $63.85 $69.20 346 796
Aug 04, 2021 $61.97 $67.61 $61.29 $63.85 284 084
Aug 03, 2021 $65.97 $68.49 $60.35 $61.74 299 607
Aug 02, 2021 $59.45 $67.60 $57.65 $65.15 616 407
Jul 30, 2021 $59.11 $60.50 $58.00 $59.43 179 660
Jul 29, 2021 $56.29 $59.94 $54.08 $58.47 325 618
Jul 28, 2021 $49.78 $57.07 $49.78 $55.56 250 392
Jul 27, 2021 $52.44 $53.49 $49.10 $49.92 291 271
Jul 26, 2021 $53.00 $54.94 $51.58 $52.52 219 834
Jul 23, 2021 $51.50 $52.45 $50.38 $52.29 319 664
Jul 22, 2021 $53.54 $54.31 $49.12 $52.13 635 548
Jul 21, 2021 $50.72 $56.22 $49.10 $54.19 400 605
Jul 20, 2021 $51.45 $53.47 $49.41 $50.86 486 059
Jul 19, 2021 $49.01 $51.23 $48.09 $51.08 480 455
Jul 16, 2021 $46.80 $51.44 $46.57 $48.57 796 611
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT